Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1996 Mar;51(3):302–305. doi: 10.1136/thx.51.3.302

Referral for lung transplantation: experience of a Birmingham Adult Cystic Fibrosis Centre between 1987 and 1994.

P J Ryan 1, D E Stableforth 1
PMCID: PMC1090644  PMID: 8779136

Abstract

BACKGROUND: Whilst much is known of the outcome of lung transplantation for patients with cystic fibrosis, less is known about those patients who are either not referred for transplantation or who die before a donor is available. The referral practice and outcome of all the cystic fibrosis patients in one clinic was documented, whether or not they were assessed for lung transplantation. The results give a perspective on the impact of the current transplantation programmes on the adult cystic fibrosis population as a whole. METHODS: A retrospective study was made of patient deaths and referrals for lung transplantation between 1987 and 1994 from the Adult Cystic Fibrosis Clinic at Birmingham Heartlands Hospital. RESULTS: The Birmingham Heartlands Adult Cystic Fibrosis Clinic has managed 192 patients since its beginning and currently cares for 141 patients. Since 1987 there have been 16 deaths in patients with cystic fibrosis who were considered unsuitable for lung transplantation. Of 49 patients referred for lung transplantation, 47 were accepted on to a provisional or active waiting list. The mean (SE) age at referral was 23.9 (0.7) years and mean (SE) forced expiratory volume in one second (FEV1) was 0.87 (0.04) 1. Fourteen patients died whilst awaiting transplantation and 19 received donor lungs. There have been 10 deaths in the transplanted group. Survival following transplantation was 58% at one year and 52% at two years. CONCLUSION: Most of the deaths that occurred in the Cystic Fibrosis Clinic were in patients who either were not considered suitable for transplantation or were still awaiting transplantation. Whilst lung transplantation is the focus for many adults with cystic fibrosis, lack of donor organs has limited the impact of transplant programmes on the clinic.

Full text

PDF
302

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dennis C., Caine N., Sharples L., Smyth R., Higenbottam T., Stewart S., Wreghitt T., Large S., Wells F. C., Wallwork J. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):893–902. [PubMed] [Google Scholar]
  2. Egan J. J., McNeil K., Bookless B., Gould K., Corris P., Higenbottam T., Webb A. K., Woodcock A. A. Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet. 1994 Aug 20;344(8921):552–553. doi: 10.1016/s0140-6736(94)91950-x. [DOI] [PubMed] [Google Scholar]
  3. Hodson M. E., Madden B. P., Steven M. H., Tsang V. T., Yacoub M. H. Non-invasive mechanical ventilation for cystic fibrosis patients--a potential bridge to transplantation. Eur Respir J. 1991 May;4(5):524–527. [PubMed] [Google Scholar]
  4. Kerem E., Reisman J., Corey M., Canny G. J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992 Apr 30;326(18):1187–1191. doi: 10.1056/NEJM199204303261804. [DOI] [PubMed] [Google Scholar]
  5. Madden B. P., Hodson M. E., Tsang V., Radley-Smith R., Khaghani A., Yacoub M. Y. Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet. 1992 Jun 27;339(8809):1583–1587. doi: 10.1016/0140-6736(92)91842-v. [DOI] [PubMed] [Google Scholar]
  6. Reitz B. A., Wallwork J. L., Hunt S. A., Pennock J. L., Billingham M. E., Oyer P. E., Stinson E. B., Shumway N. E. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982 Mar 11;306(10):557–564. doi: 10.1056/NEJM198203113061001. [DOI] [PubMed] [Google Scholar]
  7. Shah P. L., Scott S. F., Fuchs H. J., Geddes D. M., Hodson M. E. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax. 1995 Apr;50(4):333–338. doi: 10.1136/thx.50.4.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Snell G. I., de Hoyos A., Krajden M., Winton T., Maurer J. R. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest. 1993 Feb;103(2):466–471. doi: 10.1378/chest.103.2.466. [DOI] [PubMed] [Google Scholar]
  9. Starnes V. A., Lewiston N., Theodore J., Stoehr C., Stinson E., Shumway N. E., Oyer P. E. Cystic fibrosis. Target population for lung transplantation in North America in the 1990s. J Thorac Cardiovasc Surg. 1992 May;103(5):1008–1014. [PubMed] [Google Scholar]
  10. Warner J. O. Heart-lung transplantation: all the facts. Arch Dis Child. 1991 Sep;66(9):1013–1017. doi: 10.1136/adc.66.9.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES